Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,062 GBX | +0.32% | +7.05% | +13.79% |
05:51pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
05:01pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.79% | 234B | |
+32.34% | 664B | |
+29.29% | 567B | |
-7.12% | 354B | |
+19.32% | 330B | |
+4.56% | 286B | |
+4.93% | 199B | |
-9.78% | 196B | |
-5.22% | 148B | |
-10.98% | 145B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Lung Cancer Combination Treatments Improve Objective Response Rate